ClearPoint Neuro, Inc.
CLPT
$12.56
-$0.62-4.70%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 14.11% | 40.96% | 32.07% | 40.60% | 31.62% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 14.11% | 40.96% | 32.07% | 40.60% | 31.62% |
| Cost of Revenue | 7.58% | 31.58% | 1.63% | 39.58% | 54.70% |
| Gross Profit | 18.66% | 48.09% | 59.56% | 41.32% | 19.22% |
| SG&A Expenses | 15.94% | 16.77% | -0.68% | 4.07% | 23.61% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 16.14% | 24.72% | -3.70% | 6.51% | 19.42% |
| Operating Income | -19.08% | -5.62% | 33.54% | 25.93% | -5.30% |
| Income Before Tax | -16.61% | -3.43% | 37.49% | 26.08% | -5.34% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -16.61% | -3.43% | 37.49% | 26.08% | -5.34% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -16.61% | -3.43% | 37.49% | 26.08% | -5.34% |
| EBIT | -19.08% | -5.62% | 33.54% | 25.93% | -5.30% |
| EBITDA | -18.59% | -3.57% | 35.40% | 28.57% | -1.66% |
| EPS Basic | -4.05% | 7.63% | 44.06% | 28.62% | -5.04% |
| Normalized Basic EPS | -4.10% | 7.62% | 44.06% | 28.61% | -5.02% |
| EPS Diluted | -4.05% | 7.63% | 44.06% | 28.62% | -5.04% |
| Normalized Diluted EPS | -4.10% | 7.62% | 44.06% | 28.61% | -5.02% |
| Average Basic Shares Outstanding | 12.05% | 12.02% | 11.73% | 3.53% | 0.29% |
| Average Diluted Shares Outstanding | 12.05% | 12.02% | 11.73% | 3.53% | 0.29% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
